Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/01/2873589/29517/en/MannKind-Corporation-to-Hold-2024-First-Quarter-Financial-Results-Conference-Call-on-May-8-2024.html
https://www.globenewswire.com/news-release/2024/04/30/2871996/29517/en/MannKind-to-Proceed-With-Phase-1-Nintedanib-Dpi-Mnkd-201-Study-for-Pulmonary-Fibrotic-Diseases.html
https://www.globenewswire.com/news-release/2024/04/29/2871043/29517/en/MannKind-Announces-IND-Clearance-From-U-S-FDA-to-Start-Phase-3-Study-of-Clofazimine-Inhalation-Suspension-for-Nontuberculous-Mycobacterial-NTM-Lung-Disease.html
https://www.globenewswire.com/news-release/2024/04/03/2856718/29517/en/MannKind-Repays-Certain-Debt-Obligations.html
https://www.globenewswire.com/news-release/2024/03/26/2852734/29517/en/MannKind-Announces-CFO-Transition.html
https://www.globenewswire.com//news-release/2024/03/11/2843565/29517/en/INHALE-3-Study-s-Initial-Meal-Challenge-Results-Comparing-Afrezza-Head-To-Head-With-Multiple-Daily-Injections-MDI-and-Insulin-Pumps.html
https://www.globenewswire.com//news-release/2024/03/05/2840233/29517/en/MannKind-Announces-New-Clinical-Data-From-Inhale-3-Study-to-be-Presented-by-Dr-Irl-B-Hirsch-at-ATTD-on-March-8.html
https://www.globenewswire.com//news-release/2024/03/04/2839910/29517/en/MannKind-Corporation-Announces-Participation-at-Upcoming-Conferences.html
https://www.globenewswire.com//news-release/2024/02/27/2836412/29517/en/MannKind-Corporation-Reports-2023-Fourth-Quarter-and-Full-Year-Financial-Results-Provides-Clinical-Development-Update.html
https://www.globenewswire.com//news-release/2024/02/20/2831617/29517/en/MannKind-Corporation-to-Hold-2023-Fourth-Quarter-and-Full-Year-Financial-Results-Conference-Call-on-February-27-2024.html